Suwon, South Korea

Sang-Kyo Park

This inventor holds 1 USPTO granted patent. Top assignees: Fcb-Pharmicell Co., Ltd., Other. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang-Kyo Park. Retrieved from https://idiyas.com/inventor/sang-kyo-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 4 
 
Fcb-Pharmicell Co., Ltd.
 patents
silverMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sang-Kyo Park: Innovator in Stem Cell Research

Introduction

Sang-Kyo Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells into neural cells. His innovative approach has the potential to impact treatments for neurodegenerative diseases.

Latest Patents

Sang-Kyo Park holds a patent for a method that differentiates mesenchymal stem cells into neural cells. The patent, titled "Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease," outlines a process that involves culturing mesenchymal stem cells in a medium containing epidermal growth factor and hepatocyte growth factor. This method is noted for its efficiency and maturity in comparison to conventional techniques, providing a more effective means of generating neural cells.

Career Highlights

Throughout his career, Sang-Kyo Park has worked with various organizations, including Fcb-Pharmicell Co., Ltd. His work has focused on advancing the understanding and application of stem cell technology in medical science.

Collaborations

Sang-Kyo Park has collaborated with notable colleagues such as Hyun-Soo Kim and Young-Mo Kang. Their joint efforts have contributed to the advancement of research in the field of stem cell differentiation.

Conclusion

Sang-Kyo Park's innovative methods in stem cell research highlight his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…